Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Tyra Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- −3 vs. Q3 2022
- Shares held
- 35.2M
- −453.5K (−1.3%) vs. Q3 2022
- Total value
- $267.8M
- −$45.9M (−14.6%) vs. Q3 2022
- New holders
- 1
- 17 more added
- Sold out
- 4
- 11 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.52B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $778.4M |
| Q2 2025 | 121 | $541.5M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $748.6M |
| Q1 2024 | 77 | $768.4M |
| Q4 2023 | 62 | $495.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $573.0M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $313.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $494.2M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 16 | $0 | 0.00% | +16 | New |
| Credit Suisse AG | 1 | $8 | 0.00% | −72−98.6% | Reduced |
| The PNC Financial Services Group, Inc. | 58 | $441 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 89 | $676 | 0.00% | −111−55.5% | Reduced |
| Ameritas Investment Partners, Inc. | 940 | $7.40K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,405 | $10.7K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,621 | $12.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,893 | $14.0K | 0.00% | −2,310−55.0% | Reduced |
| Royal Bank of Canada | 3,344 | $25.0K | 0.00% | +3,184+1,990.0% | Added |
| Barclays PLC | 3,581 | $27.2K | 0.00% | +3,025+544.1% | Added |
| UBS Group AG | 3,587 | $27.3K | 0.00% | +3,496+3,841.8% | Added |
| Deutsche Bank AG | 5,011 | $38.1K | 0.00% | +89+1.8% | Added |
| California State Teachers Retirement System | 5,522 | $42.0K | 0.00% | +342+6.6% | Added |
| American International Group, Inc. | 6,273 | $47.7K | 0.00% | +42+0.7% | Added |
| Morgan Stanley | 10,403 | $79.1K | 0.00% | −2,119−16.9% | Reduced |
| New York State Common Retirement Fund | 10,525 | $80.0K | 0.00% | 00.0% | Unchanged |
| Sepio Capital, LP | 10,625 | $80.8K | 0.01% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 18,756 | $143.0K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 20,000 | $152.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 20,748 | $158.0K | 0.00% | +115+0.6% | Added |
| Bank of America Corp | 20,962 | $159.3K | 0.00% | +7,171+52.0% | Added |
| Fishman Jay A Ltd | 22,000 | $167.2K | 0.02% | +11,500+109.5% | Added |
| Citadel Advisors LLC | 26,717 | $203.0K | 0.00% | −13,902−34.2% | Reduced |
| D. E. Shaw & Co., Inc. | 33,005 | $250.8K | 0.00% | −1,881−5.4% | Reduced |
| Bank of New York Mellon Corp | 46,369 | $352.4K | 0.00% | +7,119+18.1% | Added |
| Wellington Management Group LLP | 78,155 | $594.0K | 0.00% | −7,027−8.2% | Reduced |
| Charles Schwab Investment Management Inc | 98,503 | $748.6K | 0.00% | +2,328+2.4% | Added |
| Northern Trust Corp | 105,767 | $803.8K | 0.00% | +1,959+1.9% | Added |
| Logos Global Management LP | 110,856 | $842.5K | 0.10% | −16,460−12.9% | Reduced |
| Sio Capital Management, LLC | 152,159 | $1.16M | 0.62% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 199,207 | $1.51M | 0.00% | −20,340−9.3% | Reduced |
| State Street Corp | 216,626 | $1.65M | 0.00% | −1,362−0.6% | Reduced |
| Geode Capital Management, LLC | 253,692 | $1.93M | 0.00% | +6,242+2.5% | Added |
| Woodline Partners LP | 299,016 | $2.27M | 0.03% | +57,917+24.0% | Added |
| Perceptive Advisors LLC | 494,403 | $3.76M | 0.11% | 00.0% | Unchanged |
| Vanguard Group Inc | 604,367 | $4.59M | 0.00% | +4,414+0.7% | Added |
| BlackRock Inc. | 655,091 | $4.98M | 0.00% | +32,993+5.3% | Added |
| Frazier Life Sciences Management, L.P. | 1,327,665 | $10.1M | 0.63% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 1,416,998 | $10.8M | 1.71% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 1,989,103 | $15.1M | 2.67% | +1,043,396+110.3% | Added |
| BVF Inc | 2,472,327 | $18.8M | 0.79% | 00.0% | Unchanged |
| Nextech Invest AG | 2,518,582 | $19.1M | 7.61% | 00.0% | Unchanged |
| FMR LLC | 3,879,123 | $29.5M | 0.00% | −147,178−3.7% | Reduced |
| Canaan Partners XI LLC | 4,409,991 | $33.5M | 26.32% | 00.0% | Unchanged |
| Boxer Capital, LLC | 6,448,359 | $49.0M | 2.64% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 7,236,454 | $55.0M | 1.12% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −743,988−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −682,018−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold out |